Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Peter StarzengrÃ¼ber; Kamala Ley-Thriemer; Rashidul Haque; Wasifali Khan; Hans Fuehrer; Anja Siedl; Verena Hofecker; Benedikt Ley; Walther Wernsdorfer; Harald Noedl

doi:10.1128/AAC.00312-09

Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Peter StarzengrÃ¼ber, Kamala Ley-Thriemer, Rashidul Haque, Wasifali Khan, Hans Fuehrer, Anja Siedl, Verena Hofecker, Benedikt Ley, Walther Wernsdorfer, Harald Noedl

Research output: Contribution to journal › Article

Abstract

Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidence
interval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

Original language	English
Pages (from-to)	4040-4042
Number of pages	3
Journal	Antimicrobial Agents and Chemotherapy
Volume	53
Issue number	9
DOIs	https://doi.org/10.1128/AAC.00312-09
Publication status	Published - 2009

Access to Document

10.1128/AAC.00312-09

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Antimalarial activity of tigecycline, a novel glycylcycline antibiotic'. Together they form a unique fingerprint.

Cite this

@article{3a1684ff1d554ba3b46244e00ed70778,

title = "Antimalarial activity of tigecycline, a novel glycylcycline antibiotic",

abstract = "Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.",

author = "Peter Starzengr{\~A}¼ber and Kamala Ley-Thriemer and Rashidul Haque and Wasifali Khan and Hans Fuehrer and Anja Siedl and Verena Hofecker and Benedikt Ley and Walther Wernsdorfer and Harald Noedl",

year = "2009",

doi = "10.1128/AAC.00312-09",

language = "English",

volume = "53",

pages = "4040--4042",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "9",

}

Antimalarial activity of tigecycline, a novel glycylcycline antibiotic. / StarzengrÃ¼ber, Peter; Ley-Thriemer, Kamala; Haque, Rashidul; Khan, Wasifali; Fuehrer, Hans; Siedl, Anja; Hofecker, Verena; Ley, Benedikt; Wernsdorfer, Walther; Noedl, Harald.

In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 9, 2009, p. 4040-4042.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

AU - StarzengrÃ¼ber, Peter

AU - Ley-Thriemer, Kamala

AU - Haque, Rashidul

AU - Khan, Wasifali

AU - Fuehrer, Hans

AU - Siedl, Anja

AU - Hofecker, Verena

AU - Ley, Benedikt

AU - Wernsdorfer, Walther

AU - Noedl, Harald

PY - 2009

Y1 - 2009

N2 - Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

AB - Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

UR - http://www.scopus.com/inward/record.url?scp=70349130353&partnerID=8YFLogxK

U2 - 10.1128/AAC.00312-09

DO - 10.1128/AAC.00312-09

M3 - Article

VL - 53

SP - 4040

EP - 4042

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -